MedPath

The Safety and Effectiveness of Zidovudine Plus Lamivudine, Used With and Without 1592U89, in HIV-1 Infected Children Who Have Taken Anti-HIV-1 Drugs

Phase 3
Completed
Conditions
HIV Infections
Registration Number
NCT00002391
Lead Sponsor
Glaxo Wellcome
Brief Summary

To compare the safety, tolerance, durability of the viral load response and the antiviral activity of the 1592U89/zidovudine(ZDV)/lamivudine (3TC) regimen vs. ZDV/3TC regimen. To determine the clinical efficacy of the two regimens as measured survival, disease progression, weight growth velocity, and neuropsychological or neurological changes. To assess the development of viral resistance and relative pharmacokinetics associated with each regimen.

Detailed Description

Patients are randomized to receive blinded treatment with ZDV/3TC alone or in combination with 1592U89, orally for 16 weeks. If after the 16-week period certain criteria are met, patients may have the option to switch to open-label treatment for the remainder of the study period.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (30)

Children's Hosp Los Angeles

🇺🇸

Los Angeles, California, United States

Children's Diagnostic Treatment Ctr

🇺🇸

Fort Lauderdale, Florida, United States

UMDNJ / Division of Allergy Immunology & Infectious Diseases

🇺🇸

Newark, New Jersey, United States

North Shore Univ Hosp / Pediatric Immunology

🇺🇸

Great Neck, New York, United States

SUNY Health Ctr at Stony Brook / Pediatric Infectious Dis

🇺🇸

Stony Brook, New York, United States

SUNY Health Sciences Ctr at Syracuse / Dept of Pediatrics

🇺🇸

Syracuse, New York, United States

Univ of Miami / Fox Cancer Research Ctr

🇺🇸

Miami, Florida, United States

Univ of Minnesota Med School

🇺🇸

Minneapolis, Minnesota, United States

Duke Univ Med Ctr / Pediatrics Dept / Infec Dis

🇺🇸

Durham, North Carolina, United States

Univ of Texas Health Sciences Ctr

🇺🇸

San Antonio, Texas, United States

Univ of Florida - Gainesville / Infectious Dis & Immun

🇺🇸

Gainesville, Florida, United States

Univ of South Florida All Children's Hosp

🇺🇸

Saint Petersburg, Florida, United States

Los Angeles County - USC Med Ctr

🇺🇸

Los Angeles, California, United States

Mt Sinai Hosp Med Ctr / Dept of Pediatrics

🇺🇸

Chicago, Illinois, United States

Bronx Lebanon Hosp Ctr / Dept of Pediatrics

🇺🇸

Bronx, New York, United States

Schneider Children's Hosp

🇺🇸

New Hyde Park, New York, United States

Cook's Ft Worth Children Med Ctr / Pediatric Inf Dis

🇺🇸

Fort Worth, Texas, United States

Children's Med Ctr of Dallas / ARMS Clinic

🇺🇸

Dallas, Texas, United States

Univ Alabama - Birmingham / Dept of Pediatrics / UAB Station

🇺🇸

Birmingham, Alabama, United States

Dr Patricia Emmanuel

🇺🇸

Tampa, Florida, United States

Pediatric Special Immunology Clinic / HRS / PBC PHU

🇺🇸

Riviera Beach, Florida, United States

PACT Program

🇺🇸

Buffalo, New York, United States

New York Hosp - Cornell / Program for Children with AIDS

🇺🇸

New York, New York, United States

St Luke's - Roosevelt Hosp Ctr

🇺🇸

New York, New York, United States

The Children's Med Ctr / Division of Infectious Dis

🇺🇸

Dayton, Ohio, United States

Eastern VA Med Sch / Children's Hosp of the King's Daughters

🇺🇸

Norfolk, Virginia, United States

Arnold Palmer Hosp for Women and Children

🇺🇸

Orlando, Florida, United States

Tulane Univ Med School

🇺🇸

New Orleans, Louisiana, United States

Univ of North Carolina / Pediatric Infectious Diseases

🇺🇸

Chapel Hill, North Carolina, United States

Med Univ of South Carolina

🇺🇸

Charleston, South Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath